This study investigates pancreatic cancer in children. It looks for genetic mutations that might increase the chance of developing this condition.
The study evaluates genetic markers in pediatric patients with acute recurrent pancreatitis and chronic pancreatitis to identify those at risk for pancreatic cancer.
- Who can participate: Children under 18 years old who have acute recurrent pancreatitis or chronic pancreatitis can participate. They must have parental consent and meet specific health criteria.
- Study details: Participants will provide blood, saliva, urine, or stool samples to identify genetic mutations. A placebo is not used in this study.
- Study timelines: The study will last 4 years.